LIPA

EtiraRx's Licensed ERX-41 Identified as a Potential New Oral Therapy for Multiple Cancers, Company Prepares for Clinical Trials

Retrieved on: 
Thursday, June 2, 2022
Endoplasmic reticulum stress in beta cells, Cell death, CEO, Glioblastoma, ER, Therapeutic index, Patient, DRS, Protein folding, LIPA, Heel, Endoplasmic reticulum, Achilles, Vaccine, Pharmaceutical industry, DALLAS, List of Nature Research journals

DALLAS, June 2, 2022 /PRNewswire/ -- A scientific team, led by the scientific founders of EtiraRx, has identified a small molecule, ERX-41, as a novel oral therapeutic agent that may have utility in treating multiple solid cancers, including triple negative breast cancer, glioblastoma, ovarian and pancreatic cancers. EtiraRx, headquartered in Biolabs Pegasus Park, plans to initiate clinical trials as early as the first quarter of 2023.

Key Points: 
  • EtiraRx, headquartered in Biolabs Pegasus Park, plans to initiate clinical trials as early as the first quarter of 2023.
  • Jung-Mo Ahn, Ganesh Raj and Ratna Vadlamudi, identified that ERX-41 dramatically enhances endoplasmic reticulum (ER) stress in cancer cells.
  • The study set the foundation for clinical trials with patients with therapy-resistant cancers that are vulnerable to enhanced ER stress.
  • Russell Hayward, CEO EtiraRx, said, "ERX-41 has the potential to be a first-in-class oral therapy that kills aggressive therapy-resistant cancers.

PSEG Long Island President and COO Daniel Eichhorn to Retire in 2022

Retrieved on: 
Monday, December 13, 2021
Heart, PEG, NYSE, Public Service Enterprise Group, LIPA, Long Island Power Authority, Dow Jones, Leadership, Technology, Customer service, Marketing, Gas, COO, PSEG, IMUST Modular Multifunction UAV, Renewable energy, Management

NEWARK, N.J., Dec. 13, 2021 /PRNewswire/ --Public Service Enterprise Group (PSEG) announced today that PSEG Long Island President and Chief Operating Officer (COO) Daniel Eichhorn will retire in 2022.

Key Points: 
  • NEWARK, N.J., Dec. 13, 2021 /PRNewswire/ --Public Service Enterprise Group (PSEG) announced today that PSEG Long Island President and Chief Operating Officer (COO) Daniel Eichhorn will retire in 2022.
  • Concurrent with Long Island Power Authority (LIPA) board consideration for approval of the proposed revised operations services agreement, Eichhorn has chosen this time to retire, giving a new leader the opportunity to make their mark on the future of the PSEG Long Island organization and its commitment to customers across Long Island and the Rockaways.
  • Eichhorn was named president and COO of PSEG Long Island in October 2017.
  • Headquartered in Newark, N.J., PSEG's principal operating subsidiaries are: Public Service Electric and Gas Co. (PSE&G), PSEG Power and PSEG Long Island.

Babylon Appoints Stock Exchange Veteran as New Board Member Ahead of Public Listing

Retrieved on: 
Wednesday, October 6, 2021
Credit Suisse First Boston, Philadelphia Stock Exchange, Senior advisor, LSEG, Boston Stock Exchange, New, Health, NASDAQ, Transport, Long Island Power Authority, Patient, Audit, London Stock Exchange, Hospital, Board, AI, Nasdaq, Inc., CEO, Acquisition, Audit committee, PALO, CFO, LIPA, Economic development, Refinitiv, OMX, Connecticut, Nasdaq, London, CS, Management

David will bring over two decades of US and UK public company experience to the Babylon board, as the company takes its final steps before listing on the New York Stock Exchange.

Key Points: 
  • David will bring over two decades of US and UK public company experience to the Babylon board, as the company takes its final steps before listing on the New York Stock Exchange.
  • "It is wonderful to welcome David to our Board and have him support our transition to becoming a public company," said Babylon CEO and Chairman, Dr. Ali Parsa.
  • "I am delighted to join the Babylon board and look forward to working with Ali, his leadership team, and the entire board at this critical point in Babylon's history," David Warren said.
  • David Warren, Babylon Board Member and Chair of the Audit Committee:
    David Warren is an exchange and bank executive who previously served as the Chief Financial Officer at the London Stock Exchange (LSEG) since 2012.

Babylon Appoints Stock Exchange Veteran as New Board Member Ahead of Public Listing

Retrieved on: 
Tuesday, September 28, 2021
Credit Suisse First Boston, Philadelphia Stock Exchange, Senior advisor, LSEG, Boston Stock Exchange, New, Health, NASDAQ, Transport, Long Island Power Authority, Patient, Audit, London Stock Exchange, Hospital, Board, AI, Nasdaq, Inc., CEO, Acquisition, Audit committee, PALO, CFO, LIPA, Economic development, Refinitiv, OMX, Connecticut, Nasdaq, London, CS, Management

David will bring over two decades of US and UK public company experience to the Babylon board, as the company takes its final steps before listing on the New York Stock Exchange.

Key Points: 
  • David will bring over two decades of US and UK public company experience to the Babylon board, as the company takes its final steps before listing on the New York Stock Exchange.
  • "It is wonderful to welcome David to our Board and have him support our transition to becoming a public company," said Babylon CEO and Chairman, Dr. Ali Parsa.
  • "I am delighted to join the Babylon board and look forward to working with Ali, his leadership team, and the entire board at this critical point in Babylon's history," David Warren said.
  • David Warren, Babylon Board Member and Chair of the Audit Committee:
    David Warren is an exchange and bank executive who previously served as the Chief Financial Officer at the London Stock Exchange (LSEG) since 2012.

Babylon Appoints Stock Exchange Veteran as New Board Member Ahead of Public Listing

Retrieved on: 
Tuesday, September 28, 2021
Credit Suisse First Boston, Philadelphia Stock Exchange, Senior advisor, LSEG, Boston Stock Exchange, New, Health, NASDAQ, Transport, Long Island Power Authority, Patient, Audit, London Stock Exchange, Hospital, Board, AI, Nasdaq, Inc., CEO, Acquisition, Audit committee, PALO, CFO, LIPA, Economic development, Refinitiv, OMX, Connecticut, Nasdaq, London, CS, Management

David will bring over two decades of US and UK public company experience to the Babylon board, as the company takes its final steps before listing on the New York Stock Exchange.

Key Points: 
  • David will bring over two decades of US and UK public company experience to the Babylon board, as the company takes its final steps before listing on the New York Stock Exchange.
  • "It is wonderful to welcome David to our Board and have him support our transition to becoming a public company," said Babylon CEO and Chairman, Dr. Ali Parsa.
  • "I am delighted to join the Babylon board and look forward to working with Ali, his leadership team, and the entire board at this critical point in Babylon's history," David Warren said.
  • David Warren, Babylon Board Member and Chair of the Audit Committee:
    David Warren is an exchange and bank executive who previously served as the Chief Financial Officer at the London Stock Exchange (LSEG) since 2012.

Getnick & Getnick Whistleblower Case Against National Grid Electric Services Leads to $6M Recovery for New York State

Retrieved on: 
Monday, September 27, 2021
Public Policy, Government, Legal, Utilities, Oil, Gas, State, Local, Courts, Energy, Professional Services, Government, Partnership, Settlement, Trust, Courage, Indian Residential Schools Settlement Agreement, State, Long Island Power Authority, Natural gas, National, Rockaway, Queens, New York City Criminal Court, Fraud, Partner, Manhattan Project, LIPA, Electricity, National Grid, See, Renewable energy, Pharmaceutical industry, Online gambling

New York Attorney General Letitia James today announced the $6 million recovery from National Grid Electric Services LLC.

Key Points: 
  • New York Attorney General Letitia James today announced the $6 million recovery from National Grid Electric Services LLC.
  • The whistleblower, whose identity remains protected, will receive 23.5 percent of the governments recovery in todays settlement.
  • This is the largest percentage that has been paid in any non-Medicaid New York False Claims Act case in which the State has elected to supersede.
  • Getnick & Getnick achieved the same percentage award for another whistleblower client in a prior case.